Compare J M Smucker Co (SJM) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs Smith & Nephew plc — how do they compare? J M Smucker Co trades at $119.83 (market cap $12.76B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: J M Smucker Co and Smith & Nephew plc are close in size by market cap, and J M Smucker Co pays the higher dividend (3.75%). Which is the better fit depends on your goals — on Pluang, investors hold J M Smucker Co for 74 Days and Smith & Nephew plc for 121 Days on average.
| SJM | SNN | |
|---|---|---|
Market Cap | $12.76B | $11.10B |
Volume | 1,300,545 | 1,051,703 |
Sector | Consumer Staples | Health |
52-Week High | $132.34 | $37.17 |
52-Week Low | $89.53 | $26.42 |
Typical Hold Time | 74 Days | 121 Days |
Enterprise Value | $19.61B | $14.13B |
Dividend Yield | 3.75% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SJM trades at $119.41, up 3.0% today, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with a consensus price target of $138.23, though high valuation ratios and recent net losses highlight fundamental challenges. Recent news highlights robust growth in segments like Uncrustables and raised fiscal 2027 guidance, but investor caution persists due to margin pressures and competitive headwinds in the consumer staples sector.
The outlook for SJM is cautiously optimistic, driven by earnings beats and strategic brand strength, but risks include volatile profitability, elevated debt, and sector competition. Upside potential exists if the company sustains revenue growth and improves net margins, aligning with analyst targets, though macroeconomic factors and execution risks could limit near-term gains.
Smith+Nephew (SNN) trades at $26.96, near its 52-week low, with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with revenue growth to $6.16B in 2025 and improving profit margins of 10.08%. Recent product launches in trauma care and surgical robotics highlight innovation, but analyst sentiment remains cautious with 65% hold ratings.
Investment outlook is mixed: solid fundamentals and product pipeline offer upside, but technical weakness and analyst skepticism pose near-term risks. Key catalysts include execution on new product adoption and margin expansion, while risks involve competitive pressures and leadership transitions following the CFO's departure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
